-
Alter M J. Prevention of spread of hepatitis C[J]. Hepatology, 2002, 36(): S93-98. doi: 10.1002/(ISSN)1527-3350
-
Brandee L. Influence of maternal human imm- unodeficiency virus (HIV) co-infection on vertical transmission of hepatitis C virus (HCV): a meta-analysis[J]. Int J Epidemiol, 2003, 32(): 727-734. doi: 10.1093/ije/dyg107
-
Brau N, Salvatore M, Rios-Bedoya C F. Slower fibrosis progression in HIV/HCV-coinfected patients with successful HIV suppression using antire- troviral therapy[J]. J Hepatol, 2006, 44(): 47-55. doi: 10.1016/j.jhep.2005.07.006
-
Busch M P, Kleinman S H, Jackson B. Nucleic acid amplification testing of blood donors for transfusion-transmitted infectious diseases: report of the Interorganizational Task Force on Nucleic Acid Amplifi- cation Testing of Blood Donors[J]. Transfusion, 2000, 40(): 143-159. doi: 10.1046/j.1537-2995.2000.40020143.x
-
Busch M P. 2001. Closing the windows on viral transmission by blood transfusion. In: Blood safety in the new millennium (Stramer S L. ed.). AABB Press: Bethesda. p33-54.
-
Cardo D M, Culver D H, Ciesielski C A. A case-control study of HIV seroconversion in health care workers after percutaneous exposure[J]. New Engl J Med, 1997, 337(): 1485-1490. doi: 10.1056/NEJM199711203372101
-
Crespo M, Sauleda S, Esteban J I. Peginterferon alpha-2b plus ribavirin vs interferon alpha-2b plus ribavirin for chronic hepatitis C in HIV-coinfected patients[J]. J Viral Hepatitis, 2007, 14(): 228-238. doi: 10.1111/jvh.2007.14.issue-4
-
Daar E S, Lynn H, Donfield S. Hepatitis Cvirus load is associated with human immunodeficiency virus type 1 disease progression in hemophiliacs[J]. J Infect Dis, 2001, 183(): 589-595. doi: 10.1086/jid.2001.183.issue-4
-
Darby S C, Ewart D W, Giangrande P L. Mortality from liver cancer and liver disease in haemophilic men and boys in UK given blood products contaminated with hepatitis C. UK Haemophilia Centre Directors' Organisation[J]. Lancet, 1997, 350(): 1425-1431. doi: 10.1016/S0140-6736(97)05413-5
-
Di Bisceglie A M. Natural history of hepatitis C: its impact on clinical management[J]. Hepatology, 2000, 31(): 1014-1018. doi: 10.1053/he.2000.5762
-
Dimitrakopoulos A, Takou A, Haida A. The prevalence of hepatitis B and C in HIV-positive Greek patients: relationship to survival of deceased AIDS patients[J]. J Infection, 2000, 40(): 127-131. doi: 10.1053/jinf.1998.0636
-
Fainboim H, Gonzalez J, Fassio E. Prevalence of hepatitis viruses in an anti-human imm- unodeficiency virus-positive population from Argentina. A multicentre study[J]. J Viral Hepatitis, 1999, 6(): 53-57. doi: 10.1046/j.1365-2893.1999.00005.x
-
Fialaire P, Payan C, Vitour D. Sustained disappearance of hepatitis C viremia in patients receiving protease inhibitor treatment for human immunodeficiency virus infection[J]. J Infect Dis, 1999, 180(): 574-575. doi: 10.1086/jid.1999.180.issue-2
-
Gavazzi G, Richallet G, Morand P. Effects of double and triple antiretroviral agents on the HCV viral load in patients coinfected with HIV and HCV[J]. Patho Biol, 1998, 46(): 412-415.
-
Giordano T P, Kramer J R, Souchek J. Cirrhosis and hepatocellular carcinoma in HIV-infected veterans with and without the hepatitis C virus: a cohort study, 1992-2001[J]. Arch Intern Med, 2004, 164(): 2349-2354. doi: 10.1001/archinte.164.21.2349
-
Greub G, Ledergerber B, Battegay M. Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study[J]. Lancet, 2000, 356(): 1800-1805. doi: 10.1016/S0140-6736(00)03232-3
-
Hoffmann C, Rockstroh J, Kamps B S. 2005. HIV and HBV/HCV Coinfections, Paris, Cagliari, Wuppertal, Sevilla: Flying Publisher, 487.
-
Landesman S H, Kalish L A, Burns D N. Obstetrical factors and the transmission of human immunodeficiency virus type 1 from mother to child. The Women and Infants Transmission Study[J]. New Engl J Med, 1996, 334(): 1617-1623. doi: 10.1056/NEJM199606203342501
-
Lauer G M, Nguyen T N, Day C L. Human immunodeficiency virus type 1-hepatitis C virus coinfection: intraindividual comparison of cellular immune responses against two persistent viruses[J]. J Virol, 2002, 76(): 2817-2826. doi: 10.1128/JVI.76.6.2817-2826.2002
-
Lesens O, Deschenes M, Steben M. Hepatitis C virus is related to progressive liver disease in human immunodeficiency virus-positive hemophiliacs and should be treated as an opportunistic infection[J]. J Infect Dis, 1999, 179(): 1254-1258. doi: 10.1086/jid.1999.179.issue-5
-
Macias J, Castellano V, Merchante N. Effect of antiretroviral drugs on liver fibrosis in HIV-infected patients with chronic hepatitis C: harmful impact of nevirapine[J]. AIDS, 2004, 18(): 767-774. doi: 10.1097/00002030-200403260-00007
-
Marcellin P, Boyer N, Gervais A. Long-term histologic improvement and loss of detectable intrahepatic HCV RNA in patients with chronic hepatitis C and sustained response to interferonalpha therapy[J]. Ann Intern Med, 1997, 127(): 875-881. doi: 10.7326/0003-4819-127-10-199711150-00003
-
Matthews-Greer J M, Caldito G C, Adley S D. Comparison of hepatitis C viral loads in patients with or without human immunodeficiency virus[J]. Clin Diagn Lab Immun, 2001, 8(): 690-694.
-
Mauss S, Rockstroh J K. HCV/HIV-coinfection-is there a state of the art after APRICOT and RIBAVIC[J]. J Antimicrob Chemoth, 2005, 56(): 615-618. doi: 10.1093/jac/dki277
-
McHutchison J G, Gordon S C, Schiff E R. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group[J]. N Engl J Med, 1998, 339(): 1485-1492. doi: 10.1056/NEJM199811193392101
-
Mohsen A H, Easterbrook P J, Taylor C. Impact of human immunodeficiency virus (HIV) infection on the progression of liver fibrosis in hepatitis C virus infected patients[J]. Gut, 2003, 52(): 1035-1040. doi: 10.1136/gut.52.7.1035
-
National Institutes of Health Consensus Development Conference Statement . Management of hepatitis C[J]. Hepatology, 2002, 36(5 Suppl 1): S3-20.
-
Neau D, Trimoulet P, Winnock M. Impact of protease inhibitors on intrahepatic hepatitis C virus viral load[J]. AIDS, 2001, 15(): 1736-1738. doi: 10.1097/00002030-200109070-00021
-
Poynard T., Marcellin P., Lee S S. Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (IHIT)[J]. Lancet, 1998, 352(): 1426-1432. doi: 10.1016/S0140-6736(98)07124-4
-
Ragni M V, Bontempo F A. Increase in hepatitis C virus load in hemophiliacs during treatment with highly active antiretroviral therapy[J]. J Infect Dis, 1999, 180(): 2027-2029. doi: 10.1086/jid.1999.180.issue-6
-
Rancinan C, Neau D, Saves M. Is hepatitis C virus co-infection associated with survival in HIV-infected patients treated by combination antiretroviral therapy[J]. AIDS, 2002, 16(): 1357-1362. doi: 10.1097/00002030-200207050-00007
-
Rutschmann O T., Negro F., Hirschel B. Impact of treatment with human immunodeficiency virus (HIV) protease inhibitors on hepatitis C viremia in patients coinfected with HIV[J]. J Infect Dis, 1998, 177(): 783-185. doi: 10.1086/jid.1998.177.issue-3
-
Sherman K E, Rouster S D, Chung R T. Hepatitis C virus prevalence among patients coinfected with human immunodeficiency virus: a cross-sectional analysis of the U.S. adult AIDS clinical trials group[J]. Clin Infect Dis, 2002, 34(): 831-837. doi: 10.1086/339042
-
Sherman M, Yoshida E M, Deschenes M. Peginterferon alfa-2a (40KD) plus ribavirin in chronic hepatitiss C patients who failed previous interferon therapy[J]. Gut, 2006, 55(): 1631-1638. doi: 10.1136/gut.2005.083113
-
Shiratori Y, Imazeki F, Moriyama M. Histologic improvement of fibrosis in patients with hepatitis C who have sustained response to interferon therapy[J]. Ann Intern Med, 2000, 132(): 517-524.
-
Soriano V, Bravo R, García-Samaniego J. Relapses of chronic hepatitis C in HIV-infected patients who responded to interferon therapy. Hepatitis/HIV Spanish Study Group. [Letter][J]. AIDS, 1997, 11(): 400-401.
-
Soto B, Rodrigo L, Garcia-Bengoechea M. Heterosexual transmission of hepatitis C virus and the possible role of coexistent human immunodeficiency virus infection in the index case. A multicentre study of 423 pairings[J]. J Intern Med, 1994, 236(): 515-519. doi: 10.1111/joim.1994.236.issue-5
-
Staples C T Jr, Rimland D, Dudas D. Hepatitis C in the HIV (human immuno- deficiency virus) Atlanta V. A. (Veterans Affairs Medical Center) Cohort Study (HAVACS): the effect of coinfection on survival[J]. Clin Infect Dis, 1999, 29(): 150-154. doi: 10.1086/524645
-
Strasfeld L, Yungtai L O, Netski D. The association of hepatitis C prevalence, activity, and genotype with HIV infection in a cohort of New York City drug users[J]. JAIDS, 2003, 33(): 356-364.
-
Sulkowski M S, Moore R D, Mehta S H. Hepatitis C and progression of HIV disease[J]. JAMA, 2002, 288(): 199-206. doi: 10.1001/jama.288.2.199
-
Tedaldi E M, Baker R K, Moorman A C. Influence of coinfection with hepatitis C virus on morbidity and mortality due to human immunodeficiency virus infection in the era of highly active antiretroviral therapy[J]. Clin Infect Dis, 2003, 36(): 363-367. doi: 10.1086/cid.2003.36.issue-3
-
Tedaldi E M, Hullsiek K H, Malvestutto C D. Prevalence and characteristics of hepatitis C virus coinfection in a human immunodeficiency virus clinical trials group: the Terry Beirn Community Programs for Clinical Research on AIDS[J]. Clin Infect Dis, 2003, 36(): 1313-1317. doi: 10.1086/cid.2003.36.issue-10
-
Tedeschi R, Pivetta E, Zanussi S. Quantification of hepatitis C virus (HCV) in liver specimens and sera from patients with human imm- unodeficiency virus coinfection by using the versant HCV RNA 3.0 (Branched DNA-Based) DNA assay[J]. J Clin Microbiol, 2003, 41(): 3046-3050. doi: 10.1128/JCM.41.7.3046-3050.2003
-
Thomas D L, Vlahov D, Solomon L. Correlates of hepatitis C virus infections among injection drug users[J]. Medicine, 1995, 74(): 212-220. doi: 10.1097/00005792-199507000-00005
-
Thomas D L, Astemborski J, Rai R M. The natural history of hepatitis C virus infection: host, viral, and environmental factors[J]. JAMA, 2000, 284(): 450-456.
-
Torre D, Tambini R, Cadario F. Evolution of coinfection with human immuno- deficiency virus and hepatitis C virus in patients treated with highly active antiretroviral therapy[J]. Clin Infect Dis, 2001, 33(): 1579-1585. doi: 10.1086/cid.2001.33.issue-9
-
Torriani F J, Soriano V. Chronic hepatitis C in HIVinfected individuals[J]. AIDS Reviews, 2000, 2(): 168-177.
-
Trimoulet P, Neau D, Le Bail B. Intrahepatic HCV RNA loads in 37 HIV-HCV co-infected patients with controlled HIV infection[J]. J Med Virol, 2002, 67(): 143-151. doi: 10.1002/jmv.v67:2
-
Velati C, Romano L, Baruffi L. Residual risk of transfusion-transmitted HCV and HIV infections by antibody-screened blood in Italy[J]. Transfusion, 2002, 42(): 989-993. doi: 10.1046/j.1537-2995.2002.00173.x
-
Verma S, Wang C H, Govindarajan S. Do type and duration of antiretroviral therapy attenuate liver fibrosis in HIV-hepatitis C viruscoinfected patients[J]. Clin Infect Dis, 2006, 42(): 262-270. doi: 10.1086/499055
-
Wright T L, Hollander H, Pu X. Hepatitis C in HIV infected patients with and without AIDS: prevalence and relationship to patient survival[J]. Hepatology, 1994, 20(): 1152-1155. doi: 10.1002/(ISSN)1527-3350
-
Yee T T, Griffioen A, Sabin C A. The natural history of HCV in a cohort of hemophilic patients infected between 1961 and 1985[J]. Gut, 2000, 47(): 845-851. doi: 10.1136/gut.47.6.845
-
Yokozaki S, Takamatsu J, Nakano I. Immunologic dynamics in hemophiliac patients infected with hepatitis C virus and human immunodeficiency virus: influence of antiretroviral therapy[J]. Blood, 2000, 96(): 4293-4299.
-
Zhang C, Yang R, Xia X. High prevalence of HIV-1 and hepatitis C virus coinfection among injection drug users in the southeastern region of Yunnan, China[J]. JAIDS, 2002, 29(): 191-196.
-
Zylberberg H, Benhamou Y, Lagneaux J L. Safety and efficacy of interferon-ribavirin combination therapy in HCV-HIV coinfected subjects: an early report[J]. Gut, 2000, 47(): 694-697. doi: 10.1136/gut.47.5.694